United States · FDA National Drug Code directory
Entecavir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-842_81e4395b-8a3e-466e-b039-0a804f171b43
- Product NDC
- 65862-842
- Form
- TABLET
- Composition / generic term
- Entecavir
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150826
- Source listing expiry
- 20261231
Source-listed ingredients
- ENTECAVIR — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (65862-842-30) / 30 TABLET in 1 BOTTLE · 65862-842-30
- 1 BOTTLE in 1 CARTON (65862-842-90) / 90 TABLET in 1 BOTTLE · 65862-842-90
- 1 BOTTLE in 1 CARTON (65862-842-99) / 1000 TABLET in 1 BOTTLE · 65862-842-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →